{
  "question": "Patient Clinical Profile:\nAge: 64 years old,Sex: M,Height: 179 cm,Body weight: 61.7 kg,BMI: 19.26,Smoking history: Former smoker,Cancer stage: Non SqCC,Histology: adenocarcinoma,Liver metastasis: Yes,Brain metastasis: Yes,EGFR status: Wild,ALK status: Negative,PD-L1 group: 1~49%,PD-L1 (22C3): 40%,PD-L1 (SP263): 1%,WBC: 18.53,Albumin: 3.2 g/dL,Lymphocyte: 1.94,Neutrophil: 15.18,LDH level: 1703.0 U/L,Treatment type: Chemotherapy + Targeted Therapy,Treatment regimen: Bevacizumab/Paclitaxel/Carboplatin,SNV mutations: ERBB2,TP53,CNV alterations: PDGFRB(gain),SDHA(gain),Fusion genes: None,Splice variants: None,TMB: 3.2 mutations/Mb\nWhat is the most likely treatment response?",
  "options": {
    "A": "Complete Response",
    "B": "Partial Response",
    "C": "Stable Disease",
    "D": "Progressive Disease"
  },
  "answer_idx": "C",
  "answer": "SD",
  "process_id": 1241,
  "options_str": "A. Complete Response\nB. Partial Response\nC. Stable Disease\nD. Progressive Disease",
  "gpt_filter_query": "<Multiple-choice Question>\nPatient Clinical Profile:\nAge: 64 years old,Sex: M,Height: 179 cm,Body weight: 61.7 kg,BMI: 19.26,Smoking history: Former smoker,Cancer stage: Non SqCC,Histology: adenocarcinoma,Liver metastasis: Yes,Brain metastasis: Yes,EGFR status: Wild,ALK status: Negative,PD-L1 group: 1~49%,PD-L1 (22C3): 40%,PD-L1 (SP263): 1%,WBC: 18.53,Albumin: 3.2 g/dL,Lymphocyte: 1.94,Neutrophil: 15.18,LDH level: 1703.0 U/L,Treatment type: Chemotherapy + Targeted Therapy,Treatment regimen: Bevacizumab/Paclitaxel/Carboplatin,SNV mutations: ERBB2,TP53,CNV alterations: PDGFRB(gain),SDHA(gain),Fusion genes: None,Splice variants: None,TMB: 3.2 mutations/Mb\nWhat is the most likely treatment response?\nA. Complete Response\nB. Partial Response\nC. Stable Disease\nD. Progressive Disease\nCorrect Answer: SD\n</Multiple-choice Question>\n\nYou are an expert in filtering and evaluating multiple-choice questions for advanced reasoning tasks. Your job is to evaluate a given question and determine whether it meets the following criteria: \n1. **Depth of Reasoning:** The question should require deeper reasoning. If the question appears too simple, mark it as \"Too Simple\".\n2. **Unambiguous Correct Answer:** The question must have a unique and unambiguous correct answer. If the question asks for \"incorrect options\" or allows for multiple correct answers, mark it as \"Ambiguous Answer\".\n3. **Open-Ended Reformulation Feasibility:** The question should be suitable for reformatting into an open-ended format. If the question cannot be easily reformulated into an open-ended problem and a clear ground-truth answer, mark it as \"Not Reformulatable\".\n\nFor each question, provide one of the following evaluations:  \n- \"Pass\" (The question meets all the criteria.)  \n- \"Too Simple\"  \n- \"Ambiguous Answer\"  \n- \"Not Reformulatable\" ",
  "gpt_filter_response": "To evaluate the multiple-choice question provided based on the given criteria, we can proceed as follows:\n\n1. **Depth of Reasoning:** The scenario presented in the clinical profile includes various complex medical parameters like PD-L1 levels, SNV mutations, CNV alterations, treatment regimen, and other clinical indicators like liver and brain metastases, neutrophil levels, and TMB. The question requires significant clinical reasoning to evaluate how these factors collectively influence the treatment response. It does not appear to be \"Too Simple.\"\n\n2. **Unambiguous Correct Answer:** The intended correct answer of \"Stable Disease\" (SD) suggests that there was an expectation of not seeing significant improvement or progression of the disease. However, the various provided parameters (like elevated LDH level and metastases) could also have been interpreted as indicative of disease progression, leading to a possible alternative interpretation of the correct answer. Given the complexity of the question and potential overlap between options, especially in clinical interpretation, this suggests a potential \"Ambiguous Answer.\"\n\n3. **Open-Ended Reformulation Feasibility:** The question could indeed be reformulated into an open-ended scenario, asking something like, \"Based on the patient's clinical profile, what is the most likely response to the treatment regimen consisting of Bevacizumab, Paclitaxel, and Carboplatin?\" This suggests it is \"Reformulatable.\"\n\nConsidering these points, the most fitting evaluation is:\n\n\"Ambiguous Answer\""
}